Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Dillon

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Drug and Alcohol Dependence|June 14, 2002
GHB use among Australians: characteristics, use patterns and associated harmLouisa Degenhardt, Shane Darke, Paul Dillon
Addictive Behaviors|June 18, 2005
Ecstasy and the concomitant use of pharmaceuticalsJan Copeland, Paul Dillon, Michael Gascoigne
Journal of the American Pharmacists Association : Japha|April 26, 2022
A Theory of Planned Behavior informed factorial survey of New York community pharmacists to determine their intentions to monitor antihypertensive medication adherence among older adultsElizabeth Unni, Jayoung Han, Paul Dillon
Harm Reduction Journal|October 6, 2005
Survey of Australians using cannabis for medical purposesWendy Swift, Peter Gates, Paul Dillon
Adicciones|December 17, 2009
Patterns and harms of pharmaceutical drug use among ecstasy users in AustraliaEdmund Silins, Jan Copeland, Paul Dillon
Drug and Alcohol Dependence|January 22, 2003
Patterns of use and harms associated with non-medical ketamine usePaul Dillon, Jan Copeland, Karl Jansen
The Australian and New Zealand Journal of Psychiatry|July 11, 2007
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of riskEdmund Silins, Jan Copeland, Paul Dillon
Substance Use & Misuse|July 29, 2005
Recent trends in the use of "club drugs": an Australian reviewLouisa Degenhardt, Jan Copeland, Paul Dillon
Addiction (Abingdon, England)|January 22, 2003
The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian usersLouisa Degenhardt, Shane Darke, Paul Dillon
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Production, purification and characterisation of genetically derived scFv and bifunctional antibody fragments capable of detecting illicit drug residuesJoanne Brennan, Paul Dillon, Richard O'Kennedy
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Drug and Alcohol Dependence|June 14, 2002
GHB use among Australians: characteristics, use patterns and associated harmLouisa Degenhardt, Shane Darke, Paul Dillon
Addictive Behaviors|June 18, 2005
Ecstasy and the concomitant use of pharmaceuticalsJan Copeland, Paul Dillon, Michael Gascoigne
Journal of the American Pharmacists Association : Japha|April 26, 2022
A Theory of Planned Behavior informed factorial survey of New York community pharmacists to determine their intentions to monitor antihypertensive medication adherence among older adultsElizabeth Unni, Jayoung Han, Paul Dillon
Harm Reduction Journal|October 6, 2005
Survey of Australians using cannabis for medical purposesWendy Swift, Peter Gates, Paul Dillon
Adicciones|December 17, 2009
Patterns and harms of pharmaceutical drug use among ecstasy users in AustraliaEdmund Silins, Jan Copeland, Paul Dillon
Drug and Alcohol Dependence|January 22, 2003
Patterns of use and harms associated with non-medical ketamine usePaul Dillon, Jan Copeland, Karl Jansen
The Australian and New Zealand Journal of Psychiatry|July 11, 2007
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of riskEdmund Silins, Jan Copeland, Paul Dillon
Substance Use & Misuse|July 29, 2005
Recent trends in the use of "club drugs": an Australian reviewLouisa Degenhardt, Jan Copeland, Paul Dillon
Addiction (Abingdon, England)|January 22, 2003
The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian usersLouisa Degenhardt, Shane Darke, Paul Dillon
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Production, purification and characterisation of genetically derived scFv and bifunctional antibody fragments capable of detecting illicit drug residuesJoanne Brennan, Paul Dillon, Richard O'Kennedy
Pageof 5